PHÂN TÍCH CHI PHÍ TRỰC TIẾP Y TẾ VÀ CÁC YẾU TỐ LIÊN QUAN TRONG ĐIỀU TRỊ BỆNH VẢY NẾN TẠI BỆNH VIỆN DA LIỄU CẦN THƠ GIAI ĐOẠN 2019 – 2021

Abstract

 Background: Psoriasis is a chronic, persistent, and recurrent dermatological disease, so the cost of treatment also differs greatly from time to time. This study analyzing the cost of psoriasis treatment in order to orient rational use of drugs in clinical pharmacy work and optimize treatment costs for patients. Objectives: To analyze the cost of psoriasis treatment and factors related to treatment costs... Materials and methods: The retrospective study carried out on the data of 97,321 patients at Can Tho Dermato-Venereology Hospital, from January 1, 2019 to December 31, 2021. Data collected included patient information, medical test results, and treatment expenses, which were subsequently processed using SPSS 26.0. Results: The average treatment cost per person ranged from 2,769,191 – 3,370,973 VND. Direct medical cost, notably medical expense cost, had the highest cost, ranging from 2,170,747 to 2,518,766 VND. Drug and paraclinical cost were also quite high. The cost of secukinumab was the highest (15,640,000 VND), the lowest was salicylic acid and methotrexate (both under 75,000 VND). Outpatient medical expense were about 9 times higher than the inpatient treatment cost. Conclusion: After three years of hospitalized psoriasis therapy, examination cost reduced over time, whereas medication, surgery, and operation cost increased. Among the psoriasis drugs, secukinumab was the highest price while the lowest is salicylic acid, methotrexate. From 2019 to 2021, psoriasis treatment expenses rised gradually due to related factors such as health insurance, location, treatment day, and comorbidities (p<0.05) which directly impacted on treatment result.